{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:28:41Z","timestamp":1791052121001,"version":"4.1.0"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"982","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Barrett's oesophagus is a frequent complication of gastro-oesophageal reflux disease predicting oesophageal adenocarcinoma. The majority of Barrett's patients will not develop cancer, so that specific methods of identification of those at risk are required. Recent molecular studies have identified a selection of candidate biomarkers that need validation in prospective studies. They reflect various changes in cell behaviour during neoplastic progression. The ASPECT trial in the UK aims to establish whether chemoprevention with aspirin and a proton pump inhibitor will reduce adenocarcinoma development and mortality in patients with Barrett's oesophagus. It will also validate biomarkers for progression and clinical response and further study disease pathogenesis.<\/jats:p>","DOI":"10.1136\/pgmj.2006.052910","type":"journal-article","created":{"date-parts":[[2007,8,3]],"date-time":"2007-08-03T18:19:03Z","timestamp":1186165143000},"page":"529-535","source":"Crossref","is-referenced-by-count":17,"title":["Molecular changes in the progression of Barrett's oesophagus"],"prefix":"10.1093","volume":"83","author":[{"given":"Edyta","family":"Zagorowicz","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Institute of Oncology , Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Jankowski","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, University of Oxford , Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,8,3]]},"reference":[{"key":"2023042013095088900_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/gut.2004.051821","article-title":"Epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"54","author":"Dent","year":"2005","journal-title":"Gut"},{"key":"2023042013095088900_bib2","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","article-title":"Prevalence of Barrett's esophagus in the general population: an endoscopic study","volume":"129","author":"Ronkainen","year":"2005","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/gast.2000.9302","article-title":"Is there publication bias in the reporting of cancer risk in Barrett's esophagus?","volume":"119","author":"Shaheen","year":"2000","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/gast.2002.31599","article-title":"Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west","volume":"122","author":"Jankowski","year":"2002","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib5","first-page":"2137","article-title":"Survival of adult cancer patients in Europe diagnosed from 1978\u20131989","volume":"34","author":"Coebergh","year":"1998","journal-title":"Eur J Cancer"},{"key":"2023042013095088900_bib6","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2004.041517","article-title":"Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?","volume":"54","author":"Lagergren","year":"2005","journal-title":"Gut"},{"key":"2023042013095088900_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gut.51.3.323","article-title":"Caucasian adults oesophagogastric junctional adenocarcinoma in oesophageal adenocarcinoma, and familial aggregation of Barrett's oesophagus","volume":"51","author":"Chak","year":"2002","journal-title":"Gut"},{"key":"2023042013095088900_bib8","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/j.1572-0241.2004.30426.x","article-title":"Risk stratification of Barrett's oesophagus: updated prospective multivariate analysis","volume":"99","author":"Weston","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2004.tb05991.x","article-title":"Proton-pump inhibitor therapy and the development dysplasia in patients with Barrett's esophagus","volume":"180","author":"Hillman","year":"2004","journal-title":"Med J Aust"},{"key":"2023042013095088900_bib11","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","article-title":"Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus","volume":"99","author":"El-Serag","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib12","first-page":"127","article-title":"Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer","volume":"9","author":"Kelloff","year":"2000","journal-title":"Cancer Epid Biom Prev"},{"key":"2023042013095088900_bib13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Ntl Cancer Inst"},{"key":"2023042013095088900_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/gast.2000.18142","article-title":"Cdx1 and cdx2 expression during intestinal development","volume":"119","author":"Silberg","year":"2000","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib15","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1073\/pnas.0502031102","article-title":"CDX1 is an important molecular mediator of Barrett's metaplasia","volume":"102","author":"Wong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023042013095088900_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/gut.2005.066209","article-title":"Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium","volume":"55","author":"Kazumori","year":"2006","journal-title":"Gut"},{"key":"2023042013095088900_bib17","first-page":"94","article-title":"Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia","volume":"37","author":"Eda","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"2023042013095088900_bib18","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/00000478-200311000-00006","article-title":"Cdx2 as a marker of epithelial intestinal differentiation in the esophagus","volume":"27","author":"Phillips","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2023042013095088900_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/jcp.2003.015727","article-title":"The homeodomain protein CDX2 is an early marker of Barrett's oesophagus","volume":"57","author":"Moons","year":"2004","journal-title":"J Clin Pathol"},{"key":"2023042013095088900_bib20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0002-9440(10)65346-1","article-title":"Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus","volume":"154","author":"Jankowski","year":"1999","journal-title":"Am J Pathol"},{"key":"2023042013095088900_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1052-5157(03)00006-0","article-title":"Biomarkers in Barrett's esophagus","volume":"13","author":"Reid","year":"2003","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"2023042013095088900_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"2023042013095088900_bib23","first-page":"8284","article-title":"p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium","volume":"61","author":"Wong","year":"2001","journal-title":"Cancer Res"},{"key":"2023042013095088900_bib24","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1158\/0008-5472.CAN-04-1738","article-title":"The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma","volume":"64","author":"Maley","year":"2004","journal-title":"Cancer Res"},{"key":"2023042013095088900_bib25","first-page":"2619","article-title":"p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas","volume":"57","author":"Wong","year":"1997","journal-title":"Cancer Res"},{"key":"2023042013095088900_bib26","first-page":"5021","article-title":"Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma","volume":"60","author":"Eads","year":"2000","journal-title":"Cancer Research"},{"key":"2023042013095088900_bib27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/gast.2002.32370","article-title":"p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus","volume":"122","author":"Bian","year":"2002","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib28","first-page":"457","article-title":"Increased expression of the cyclin D1 gene in Barrett's esophagus","volume":"5","author":"Arber","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2023042013095088900_bib29","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jnci\/92.16.1316","article-title":"Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma","volume":"92","author":"Bani-Hani","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2023042013095088900_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0016-5085(19)31680-4","article-title":"Cell proliferation in esophageal columnar epithelium (Barrett's esophagus)","volume":"75","author":"Herbst","year":"1978","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib31","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/0016-5085(92)91433-5","article-title":"Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization","volume":"103","author":"Gray","year":"1992","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/gut.21.1.26","article-title":"Cell proliferation in three types of Barrett's epithelium","volume":"21","author":"Pellish","year":"1980","journal-title":"Gut"},{"key":"2023042013095088900_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0016-5085(87)90306-4","article-title":"Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma","volume":"93","author":"Reid","year":"1987","journal-title":"Gastroenterology"},{"issue":"4","key":"2023042013095088900_bib34","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/0016-5085(92)90758-Q","article-title":"Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort","volume":"102","author":"Reid","year":"1992","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur J Cancer"},{"key":"2023042013095088900_bib36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<652::AID-CNCR4>3.0.CO;2-M","article-title":"In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma","volume":"83","author":"Morales","year":"1998","journal-title":"Cancer"},{"key":"2023042013095088900_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1091-255X(00)80049-9","article-title":"Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence","volume":"4","author":"Lord","year":"2000","journal-title":"J Gastrointest Surg"},{"key":"2023042013095088900_bib38","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/nar\/25.13.2595","article-title":"Advances in quantification, characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)","volume":"25","author":"Kim","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"2023042013095088900_bib39","first-page":"85","article-title":"Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus","volume":"6","author":"Going","year":"2004","journal-title":"Neoplasia"},{"key":"2023042013095088900_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1097-0320(19981215)34:6<257::AID-CYTO3>3.0.CO;2-S","article-title":"DNA\/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients","volume":"34","author":"Teodori","year":"1998","journal-title":"Cytometry"},{"key":"2023042013095088900_bib41","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1073\/pnas.93.14.7081","article-title":"17p (p53) allelic losses, 4N (G2\/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus","volume":"93","author":"Galipeau","year":"1996","journal-title":"PNAS"},{"key":"2023042013095088900_bib42","first-page":"669","article-title":"Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high risk patient subsets","volume":"95","author":"Reid","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib43","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/j.1572-0241.2001.05261.x","article-title":"Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables","volume":"96","author":"Rabinowitch","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib44","first-page":"430","article-title":"Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer","volume":"20","author":"Muzeau","year":"1996","journal-title":"Gastroenterol Clin Biol"},{"key":"2023042013095088900_bib45","first-page":"559","article-title":"p53 is frequently mutated in Barrett's metaplasia of the intestinal type","volume":"5","author":"Campomenosi","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2023042013095088900_bib46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1023\/A:1026608319881","article-title":"Role of p53 assessment in management of Barrett's esophagus","volume":"44","author":"Kubba","year":"1999","journal-title":"Dig Dis Sci"},{"key":"2023042013095088900_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/8816","article-title":"Evolution of neoplastic cell lineages in Barrett oesophagus","volume":"22","author":"Barrett","year":"1999","journal-title":"Nat Genet"},{"key":"2023042013095088900_bib48","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1111\/j.1572-0241.2001.04236.x","article-title":"Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression","volume":"96","author":"Reid","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/32918","article-title":"E-cadherin germline mutations in familial gastric cancer","volume":"392","author":"Guilford","year":"1998","journal-title":"Nature"},{"key":"2023042013095088900_bib50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/hmg\/8.4.607","article-title":"Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer","volume":"8","author":"Richards","year":"1999","journal-title":"Hum Mol Genet"},{"key":"2023042013095088900_bib51","first-page":"1808","article-title":"E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study","volume":"90","author":"Swami","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib52","first-page":"135","article-title":"Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation","volume":"152","author":"Bailey","year":"1998","journal-title":"Am J Pathol"},{"key":"2023042013095088900_bib53","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1038\/sj.onc.1205731","article-title":"Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action","volume":"21","author":"selepis","year":"2002","journal-title":"Oncogene"},{"key":"2023042013095088900_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Non-steroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2023042013095088900_bib55","first-page":"2929","article-title":"Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated carcinomas","volume":"58","author":"Wilson","year":"1998","journal-title":"Cancer Res"},{"key":"2023042013095088900_bib56","first-page":"990","article-title":"Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence","volume":"96","author":"Morris","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib57","first-page":"487","article-title":"Cyclooxygenase-2 expression in Barrett's oesophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure","volume":"118","author":"hirvani","year":"2000","journal-title":"Gastroenterol Clin Biol"},{"key":"2023042013095088900_bib58","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/gast.2002.33580","article-title":"Prognostic significance of elevated cyclooxygenase expression in patients with adenocarcinoma of the esophagus","volume":"122","author":"Buskens","year":"2002","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib59","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/sj.bjc.6690577","article-title":"E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus","volume":"80","author":"Wijnhoven","year":"1999","journal-title":"Br J Cancer"},{"key":"2023042013095088900_bib60","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/jnci\/92.22.1805","article-title":"Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma","volume":"92","author":"Kawakami","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2023042013095088900_bib61","first-page":"3410","article-title":"Epigenetic patterns in the progression of esophageal adenocarcinoma","volume":"61","author":"Eads","year":"2001","journal-title":"Cancer Res"},{"key":"2023042013095088900_bib62","first-page":"2912","article-title":"Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma","volume":"9","author":"Brock","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2023042013095088900_bib63","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1073\/pnas.94.13.6770","article-title":"Purification and molecular cloning of a secreted, frizzled-related antagonist of Wnt action","volume":"94","author":"Finch","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023042013095088900_bib64","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ijc.21045","article-title":"Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus","volume":"116","author":"Zou","year":"2005","journal-title":"Int J Cancer"},{"key":"2023042013095088900_bib65","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications","volume":"54","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"key":"2023042013095088900_bib66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0016-5107(99)70482-7","article-title":"Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia","volume":"49","author":"Falk","year":"1999","journal-title":"Gastrointest Endosc"},{"key":"2023042013095088900_bib67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/gut.43.2.216","article-title":"Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma","volume":"43","author":"van Sandick","year":"1998","journal-title":"Gut"},{"key":"2023042013095088900_bib68","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0046-8177(88)80344-7","article-title":"Observer variation in the diagnosis of dysplasia in Barrett's esophagus","volume":"19","author":"Reid","year":"1988","journal-title":"Hum Pathol"},{"key":"2023042013095088900_bib69","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/j.1572-0241.2000.02234.x","article-title":"Long-term follow-up of Barrett's high-grade dysplasia","volume":"95","author":"Weston","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib70","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1053\/gast.2001.25111","article-title":"Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma","volume":"120","author":"Buttar","year":"2001","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib71","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1053\/gast.2001.25065","article-title":"Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia","volume":"120","author":"Schnell","year":"2001","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib72","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1572-0241.2001.03596.x","article-title":"Barrett's esophagus: from process to outcomes","volume":"96","author":"Sharma","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib73","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1572-0241.2001.03851.x","article-title":"p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression","volume":"96","author":"Weston","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2023042013095088900_bib74","first-page":"A20","article-title":"Natural history of low grade dysplasia - an infrequent finding which usually regresses-preliminary results from the Barrett's esophagus study","volume":"122","author":"Sharma","year":"2002","journal-title":"Gastroenterology"},{"key":"2023042013095088900_bib75","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jnci\/djh171","article-title":"Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus","volume":"96","author":"Jankowski","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"2023042013095088900_bib76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/9780470987513.ch24","volume-title":"Barrett's esophagus and adenocarcinoma of the esophagus","author":"Jankowski","year":"2006"},{"key":"2023042013095088900_bib77","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2559.2003.01627.x","article-title":"Cyclooxygenase-2 is expressed frequently and early in Barrett's esophagus and associated adenocarcinoma","volume":"42","author":"Lagorce","year":"2003","journal-title":"Histopathology"},{"key":"2023042013095088900_bib78","doi-asserted-by":"crossref","first-page":"G327","DOI":"10.1152\/ajpgi.00543.2001","article-title":"Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent","volume":"283","author":"Kaur","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2023042013095088900_bib79","first-page":"2560","article-title":"Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus","volume":"7","author":"Siriex","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2023042013095088900_bib80","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1158\/1078-0432.CCR-04-1091","article-title":"Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR","volume":"11","author":"Mitas","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2023042013095088900_bib81","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3748\/wjg.v10.i21.3194","article-title":"Gene expression profiling in Barrett's esophagus and cardia intestinal metaplasia: a comparative analysis using cDNA microarray","volume":"10","author":"Chang","year":"2004","journal-title":"World J Gastroenterol"},{"key":"2023042013095088900_bib82","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1158\/1078-0432.CCR-04-1280","article-title":"Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma","volume":"11","author":"Helm","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2023042013095088900_bib83","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1442-2050.2005.00488.x","article-title":"Analysis of protein expression patterns in Barrett's esophagus using MALDI mass spectrometry, in search of malignancy biomarkers","volume":"18","author":"Streitz","year":"2005","journal-title":"Dis Esophagus"},{"key":"2023042013095088900_bib84","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J Natl Cancer Inst"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/83\/982\/529\/50023231\/postgradmedj-83-529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/83\/982\/529\/50023231\/postgradmedj-83-529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T16:26:04Z","timestamp":1682007964000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/83\/982\/529\/7045369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":84,"journal-issue":{"issue":"982","published-online":{"date-parts":[[2007,8,3]]},"published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2006.052910","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,8]]},"published":{"date-parts":[[2007,8,1]]}}}